Decoding the Future of K-Bio Value
Navigating the Quantum Leap of K-Bio
-
K-Bio Industry Overview: 2025 Performance and 2026 Outlook In 2025, the K-Bio industry demonstrated solid growth, driven by expanding global demand for biopharmaceuticals and the strengthening competitiveness of Korean biotech companies. Exports of biopharmaceutical products increased steadily, supported by large-scale biologics manufacturing, growing biosimilar penetration, and continued progress in innovative…
-
Korea’s Serial Deal-Maker: From Lazertinib Royalties to a Global Licensing Platform Ticker KOSDAQ: 039200 Current Price (June 2026) ~42,200 KRW Market Cap ~1.6 trillion KRW (~USD 1.2B) Sector Biopharma / Drug Discovery Report Date Jun 07, 2026 1. Executive Summary Oscotec Inc. (KOSDAQ: 039200) is a South Korean clinical-stage biotechnology…
● Latest Articles
-
Alteogen
Alteogen is evolving from a platform provider into a global biopharmaceutical powerhouse. Its strategy is anchored by the Hybrozyme (ALT-B4) platform, which is currently the…
-
OliX Pharmaceuticals
OliX Pharmaceuticals is moving beyond the liver to own the “non-liver” RNAi delivery platforms of the future. Its strategy is focused on cp-asiRNA for local…
-
Chong Kun Dang (CKD)
Technical Analysis: The Power of Open Innovation & Commercialization Chong Kun Dang has solidified its position by expertly blending proprietary drug development with strategic in-licensing…
-
Celltrion vs. Samsung Bioepis: Which One Holds the Global Edge?
For everyday investors, choosing between South Korea’s two biotech titans—Celltrion and Samsung Bioepis—often feels like choosing between a “pioneering architect” and a “master manufacturer.” As…
● About Me
“PhD Scientist & 10-Year K-Bio Investor: Decoding the Life Science of Value.”
I am a Life Sciences PhD with industrial R&D experience across mAbs, BsAbs, ADCs, Vaccines, Cell/Gene Therapy and Medical Devices. By merging my technical expertise with over a decade of active investment in the K-Bio market, I translate complex innovation into clear, data-driven insights to help you find the real value behind the jargon.
K-Bio Value Report 